GH Medina Manuel Hidalgo sells $131K worth of shares
Dec 13, 2025, 5:36 PM
0.00%
What does GH do
Guardant Health, a precision oncology company based in Palo Alto, California, specializes in blood-based cancer tests and advanced analytics, employing 1,779 staff since its IPO in October 2018. Its tests, including Guardant360 and Guardant Reveal, aid in early cancer detection, monitoring recurrence, and treatment selection for various cancer stages.
Medina Manuel Hidalgo sold 1,250 shares of GH on 8 December at $105.00 per share, worth a total of $131K. They now own 1,047 GH shares, or a 61% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.